Relation between DNA repair, apoptosis and chromosomal aberrations in presence of pifithrin-α, an inhibitor of p53

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 701, Issue 1, 2010, Pages 92-97

  Meschini, Roberta ^a   Berni, Andrea ^a   Ortenzi, Vincenza ^a   Mancinelli, Pierluigi ^a   Palitti, Fabrizio ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Apoptosis; Chromosomal aberrations; DNA repair; HPBL; P53; Pifithrin

Indexed keywords

BROXURIDINE; PHOSPHATE BUFFERED SALINE; PHYTOHEMAGGLUTININ; PIFITHRIN ALPHA; PROTEIN P53; BENZOTHIAZOLE DERIVATIVE; PIFITHRIN; TOLUENE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL DEATH; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; COMET ASSAY; CONTROLLED STUDY; DICENTRIC CHROMOSOME; DNA DAMAGE; DNA REPAIR; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; X IRRADIATION; ALPHA RADIATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; LINEAR ENERGY TRANSFER; LYMPHOCYTE; MICRONUCLEUS; NEUTRON; RADIATION RESPONSE; X RAY;

ALPHA PARTICLES; APOPTOSIS; BENZOTHIAZOLES; CHROMOSOME ABERRATIONS; DNA REPAIR; G0 PHASE; HUMANS; LINEAR ENERGY TRANSFER; LYMPHOCYTES; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEUTRONS; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; X-RAYS;

EID: 77955093935     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.03.017     Document Type: Article

References (37)

1. Lowe S.W., Cepero E., Evan G. Intrinsic tumour suppression. Nature 2004, 432:307-315.
2. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
3. Vousden K.H., Prives C. p53 and prognosis: new insights and further complexity. Cell 2005, 120:7-10.
4. Yin Y, Tainsky M.A., Bishoff F.Z., Strong L.C., Wahl G.M. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992, 70:937-944.
5. Schmid P., Lorenz A., Hameister H., Montenarh M. Expression of p53 during mouse embryogenesis. Development 1991, 113:857-865.
6. Komarova E.A., Chernov M.V., Franks R., Wang K., Armin G., Zelnick C.R., Chin D.M., Bacus S.S., Stark G.R., Gudkov A.V. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 1997, 16:1391-1400.
7. Komarova E.A., Gudkov A.V. Could p53 be a target for therapeutic suppression? Semin. Cancer Biol. 1998, 8:389-400.
8. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tsekov K., Coon J.S., Chernov M.V., Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285:1733-1737.
9. Toillon R.A., Chopin V., Jouy N., Fauquette W., Boilly B., Le Bourthis X. Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells. Breast Cancer Res. Treat. 2002, 71:269-280.
10. Zhang Z., Huang C., Li J., Shi X. Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141 cells. J. Inorg. Biochem. 2002, 89:142-148.
11. Pani L., Horal M., Loeken M.R. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes. Dev. 2002, 16:676-680.
12. Alves da Costa C., Paitel E., Mattson M.P., Amson R., Telerman A., Ancolio K., Checler F. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons. Proc. Natl. Acad. Sci. USA 2002, 99:4043-4048.
13. Shih A., Davis F.B., Lin H.Y., Davis P.J. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J. Clin. Endocrinol. Metab. 2002, 87:1223-1232.
14. Havre P.A., O'Reilly S., McCormick J.J., Brash D.E. Transformed and tumor-derived human cells exhibit preferential sensitivity to the thiol antioxidants, N-acetyl cysteine and penicillamine. Cancer Res. 2002, 62:1443-1449.
15. Bassi L., Carloni M., Fonti E., Palma de la Pena N., Meschini R., Palitti F. Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro. Mutat. Res. 2002, 499:163-176.
16. Chopin V., Toillon R.A., Jouy N., Le Bourhis X. Sodium butyrate induces p53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br. J. Pharmacol. 2002, 135:79-86.
17. Lorenzo E., Ruiz-Ruiz C., Quesada A.J., Hernandez G., Rodriguez A., Lopez-Rivas A., Redondo J.M. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J. Biol. Chem. 2002, 277:10883-10892.
18. Mahyar-Roemer M., Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001, 20:3387-3398.
19. Arango D., Corner G.A., Wadler S., Catalano P.J., Augenlicht L.H. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res. 2001, 61:4910-4915.
20. Lakkaraju A., Dubinsky J.M., Low W.C., Rahman Y.E. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes. J. Biol. Chem. 2001, 276:32000-32007.
21. Culmsee C., Zhu X., Yu Q.S., Chan S.L., Camandola S., Guo Z., Greig N.H., Mattson M.P. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 2001, 77:220-228.
22. Komarova E.A., Gudkov A.V. Suppression of p53: a new approach to overcome side effects of antitumour. Biochem. (Moscow) 2000, 65:41-48.
23. Albrechtsen N., Dornreiter I., Grosse F., Kim E., Wiesmuller L., Deppert W. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53. Oncogene 1999, 18:7706-7717.
24. Bertrand P., Saintigny Y., Lopez B.S. P53's double life: transactivation-independent repression of homologous recombination. Trends Genet. 2004, 20:235-243.
25. Sengupta S., Harris C.C. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 2005, 6:44-55.
26. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Envirom. Mol. Mutagen. 2000, 3:206-211.
27. Perry P., Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature 1974, 251:156-158.
28. Wyllie A.H., Kerr J.F.R., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980, 68:251-303.
29. Hewitson T.D., Darby I.A. In situ localization of apoptosis using tunnel. Methods Mol. Biol. 2010, 611:161-170.
30. Savage J.R.K. Classification and relationships of induced chromosomal structural changes. J. Med. Genet. 1975, 13:103-122.
31. Al Rashid S.T., Dellaire G., Cuddihy A., Jalali F., Vaid M., Coackley C., Folkard M., Xu Y., Chen B.P., Chen D.J., Lilge L., Prise K.M., Bazett Jones D.P., Bristow R.G. Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res. 2005, 65:10810-10821.
32. Bassi L., Carloni M., Meschini R., Fonti E., Palitti F. X-irradiated human lymphocytes with unstable aberrations and their preferential elimination by p53/survivin-dependent apoptosis. Int. J. Radiat. Biol. 2003, 79:943-954.
33. Brown J.M., Evans J.W., Kovacs M.S. Mechanism of chromosome exchange formation in human fibroblasts: insights from "chromosome painting". Environ. Mol. Mutat. 1993, 22:218-224.
34. Lobrich M., Rydberg B., Cooper P.K. Repair of x-ray-induced DNA double-strand breaks in specific Not I restriction fragments in human fibroblasts: joining of correct and incorrect ends. Proc. Natl. Acad. Sci. USA 1995, 92:12050-12054.
35. 0 human lymphocytes. Int. J. Radiat. Biol. 2005, 81:587-599.
36. Bauchinger M., Schimid E., Braselmann H. Cell survival and radiation induced chromosome aberrations. II. Experimental findings in human lymphocytes analysed in first and second post-irradiation metaphases. Radiat. Environ. Biophys. 1986, 25:253-260.
37. 0 human lymphocytes bearing dicentric chromosomes. Radiat. Res. 2008, 169:181-187.